SC-11800 EE (Demulen)

contains ethynodiol diacetate & ethinyl estradiol

Also Known As:

Demulen; (17 alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol, mixt. with (3 beta,17 alpha)-19-norpregn-4-en-20-yne-3,17-diol diacetate; Bisecurin II; Conova 30; Lestrin; Ovulen 50; Ovulen-50; SC 11800 EE

Networked: 7 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Pierson, Roger A: 1 article (11/2005)
2.	Sarty, Gordon E: 1 article (11/2005)

Related Diseases

1.	Thromboembolism 01/01/1987 - " Among about 20 women whose lipid metabolism was investigated, no effect of Conova 30 was found and no thromboembolism phenomena were seen during this study. "
2.	Infertility (Sterility) 11/01/2005 - "Fifty-four women enrolled in an ovarian superstimulation program of therapy for the amelioration of idiopathic infertility had their ovarian cycles synchronized by taking Demulen 30 for two weeks prior to the study. "
3.	Neoplastic Processes 12/01/1987 - "Effect of treatment of female rats with an oral contraceptive agent (OCA), Ovulen-50, for 7 weeks on agglutination of hepatocytes with concanavalin A (con A) and activities of certain tumor marker enzymes were examined to find out if OCA treatment is related to preneoplastic or neoplastic processes. "
4.	Muscle Spasticity (Spastic) 01/01/1987 - " 6 women reported breast tension and 2 reported that spastic dysmenorrhea had disappeared since they started Conova 30. "
5.	Infections 02/01/1970 - " Only 1 Demulen patient developed asymptomatic tract infection. "

Related Drugs and Biologics

1.	Oral Contraceptives
2.	Tumor Biomarkers (Tumor Markers)
3.	Spironolactone (Aldactone)
4.	Ethynodiol Diacetate
5.	Enzymes
6.	Concanavalin A
7.	Bisecurin I (Ovulen)

Related Therapies and Procedures

1.	Therapeutics